Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
New medicines: human
Get the latest updates from New medicines: human directly as they happen.
Follow now 543 followers
Latest posts
Last updated 2 days ago
Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Status: Opinion
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Daybu, trofinetide, Status: Opinion
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Status: Opinion
Human medicines European public assessment report (EPAR): mCOMBRIAX, Influenza,COVID-19 mRNA vaccine, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): mCOMBRIAX, Influenza,COVID-19 mRNA vaccine, Status...
Human medicines European public assessment report (EPAR): Palsonify, paltusotine, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Palsonify, paltusotine, Status: Opinion
Human medicines European public assessment report (EPAR): Iloperidone Vanda Pharmaceuticals, iloperidone, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Iloperidone Vanda Pharmaceuticals, iloperidone, Status...
Human medicines European public assessment report (EPAR): Rhapsido, remibrutinib, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Rhapsido, remibrutinib, Status: Opinion
Human medicines European public assessment report (EPAR): Zandoriah, teriparatide, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Zandoriah, teriparatide, Status: Opinion
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Poherdy, pertuzumab, Status: Opinion
Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Status: Opinion
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Tuyory, tocilizumab, Status: Opinion
Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Status: Opinion
2 days ago
Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Status: Opinion